PROGENICS PHARMACEUTICALS INC·4

Mar 2, 2:22 PM ET

Osorio Benedict 4

4 · PROGENICS PHARMACEUTICALS INC · Filed Mar 2, 2018

Insider Transaction Report

Form 4
Period: 2018-03-01
Osorio Benedict
Senior Vice President, Quality
Transactions
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2018-03-01+100,000100,000 total
    Exercise: $6.62Exp: 2028-03-01Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The stock options become exercisable in five equal installments, commencing one year from the grant date.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT